425: Gentherm Reports Q2 2026 Results, Raises Guidance, Approves New Buyback

Gentherm announced strong second quarter 2026 financial results, exceeding expectations with record revenue, and raised its full-year guidance, while also authorizing a new $400 million stock repurchase program.

Summary

• Gentherm reported record second quarter 2026 product revenues of $416.2 million, an increase of 11.0% year-over-year (9.5% excluding foreign currency impact).
• The company raised its full-year 2026 guidance for Product Revenues to $1.55B - $1.65B, Adjusted EBITDA to $185M - $200M, and Adjusted Free Cash Flow to $85M - $100M.
• A new stock repurchase program of up to $400 million was authorized, replacing the previous program and set to expire in July 2029.
• The company completed key sign-to-close deliverables for its planned combination with Modine Performance Technologies, which remains on track for an early fourth quarter 2026 close.
• Gentherm also acquired Innovative Medical Equipment, LLC, expanding its medical product portfolio.
• Net income for the quarter was $4.4 million, a significant improvement from $0.5 million in the prior year.
• Adjusted EBITDA was $48.8 million, representing 11.7% of revenue.
• Cash flow from operations was $2.3 million, a decrease from $31.7 million in the prior year, primarily due to restructuring and M&A expenses.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a positive report, with strong revenue growth, raised guidance, and a significant new stock repurchase program, despite some margin pressure and lower operating cash flow due to specific expenses.

Positives

• Record quarterly revenue of $416.2 million, up 11.0% year-over-year.
• Full-year 2026 guidance raised for revenue, Adjusted EBITDA, and Adjusted Free Cash Flow.
• New $400 million stock repurchase program authorized, demonstrating confidence in future cash flow and commitment to shareholder value.
• Automotive Climate and Comfort Solutions revenue increased 14.1% year-over-year, outperforming market production by 14 percentage points.
• Acquisition of Innovative Medical Equipment, LLC, to broaden product portfolio and expand channel access.
• Net income improved significantly to $4.4 million from $0.5 million in the prior year.
• Adjusted diluted earnings per share increased to $0.75 from $0.54 in the prior year.
• Net leverage remains low at approximately 0.3x, with liquidity of $502.3 million.

Negatives

• Gross margin decreased slightly to 23.2% from 23.9% year-over-year, primarily due to higher material costs and warranty accruals.
• Cash flow from operations decreased significantly to $2.3 million from $31.7 million year-over-year, attributed to restructuring and M&A expenses.
• Medical segment revenue decreased by 0.2% year-over-year (excluding FX).

Risks

• Potential for delays or failure to complete the proposed transaction with Modine Performance Technologies.
• Uncertainty of the expected financial performance of the combined company post-transaction.
• Failure to realize anticipated benefits of the Modine transaction, including revenue and cost synergies.
• Risks associated with integrating the businesses of Gentherm and SpinCo.
• Potential for unexpected costs, charges, or expenses resulting from the Modine transaction.
• Evolving legal, regulatory, and tax regimes.
• Changes in general economic and industry-specific conditions, including volatility from tariffs and trade policies.
• Risks related to the disruption of management time from ongoing business operations due to the pendency of the Proposed Transaction.

Future Outlook

Gentherm raised its full-year 2026 guidance, projecting Product Revenues between $1.55 billion and $1.65 billion, Adjusted EBITDA between $185 million and $200 million, and Adjusted Free Cash Flow between $85 million and $100 million. The company anticipates light vehicle production in its relevant markets to decrease at a low single-digit rate for the full year 2026 compared to 2025, with a EUR to USD exchange rate of $1.16/Euro and an effective tax rate of approximately 30%. This guidance does not reflect any impact from the planned combination with Modine Performance Technologies.

Management Comments

• "The Gentherm team demonstrated strong commercial performance with record quarterly revenue, while also scaling our core technologies into new markets. Our growth initiatives in both home and office, and medical markets continued to accelerate."
• "In addition, I was pleased with our execution during the quarter. The operating systems and key performance indicators we have put in place to drive more rigor and standardization throughout the business are yielding positive results."
• "Our strong first half performance puts us on track to deliver a solid year and gives us confidence in raising our 2026 guidance. We continue to transform the Company for profitable growth, margin expansion, and driving shareholder returns."
• "With a strong balance sheet and access to capital, we are well positioned to execute our strategic priorities while maintaining a disciplined approach to capital allocation."
• "The Board's authorization of a new stock repurchase program underscores our confidence in the business's long-term cash flow generation and our commitment to creating value for shareholders."

Industry Context

StockSavvy.ai notes that Gentherm's Q2 2026 results, including revenue growth and raised guidance, indicate resilience and strategic execution within the automotive thermal management sector, which is navigating shifts towards EVs and autonomous driving. The acquisition of Innovative Medical Equipment also signals diversification efforts beyond the automotive core.

Comparison to Industry Standards

• Gentherm's Automotive Climate and Comfort Solutions revenue growth of 14.1% (12.7% ex-FX) outperformed S&P Global's mid-July light vehicle production report in its relevant markets by 14 percentage points, suggesting strong market share gains or product demand.
• The Adjusted EBITDA margin of 11.7% for Q2 2026 is within the typical range for specialized automotive component suppliers, though slightly lower than the prior year's 12.2%.
• The company's focus on thermal management technologies aligns with industry trends towards enhanced vehicle comfort and battery thermal management in electric vehicles.

Stakeholder Impact

• Shareholders: Benefit from the new $400 million stock repurchase program, signaling a commitment to returning capital and confidence in future value creation. Improved earnings per share also positively impacts shareholder value.
• Employees: Potential for increased stability and growth opportunities if the Modine transaction is successful and integration is smooth. Restructuring expenses may have implications for workforce adjustments.
• Customers: Continued innovation in thermal management and pneumatic comfort technologies, with expansion into the medical sector potentially offering new solutions.
• Suppliers: Increased demand for materials and components driven by revenue growth, though higher material costs could impact margins for both Gentherm and its suppliers.

Next Steps

• Complete the planned combination with Modine Performance Technologies by early fourth quarter 2026.
• Integrate Innovative Medical Equipment, LLC into Gentherm's operations.
• Execute the new $400 million stock repurchase program over the next three years.
• Continue to drive growth initiatives in home and office, and medical markets.
• Focus on profitable growth, margin expansion, and shareholder returns.

Key Dates

Recommendation

The company is performing well with raised guidance and a new buyback, but the pending Modine transaction introduces significant integration risks and uncertainties. While positives are evident, the potential for delays, integration challenges, and the impact on future financial performance warrant a cautious 'hold' until the transaction is closer to completion and its benefits are clearer.

Keywords

Thermal Management, Climate Control, Automotive Technology, Medical Devices, Stock Repurchase, Financial Results, Guidance Update, Merger